These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7294654)

  • 1. [Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)].
    Choay J; Lormeau JC; Petitou M; Fareed J; Sinaÿ P
    Ann Pharm Fr; 1981 Jul; 39(3):267-72. PubMed ID: 7294654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].
    Choay J; Lormeau JC; Petitou M
    Ann Pharm Fr; 1981 May; 39(1):37-44. PubMed ID: 7247232
    [No Abstract]   [Full Text] [Related]  

  • 3. [New antithrombotic oligosaccharides].
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new type of antithrombotic agent: action of antithrombin III - factor Xa complex.
    Bajwa SS
    Proc West Pharmacol Soc; 1981; 24():275-9. PubMed ID: 7255468
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.
    Petitou M; Lormeau JC; Choay J
    Nature; 1991 Apr; 350(6319 Suppl):30-3. PubMed ID: 2017262
    [No Abstract]   [Full Text] [Related]  

  • 7. Approaches for designing synthetic, low molecular weight inhibitors of clotting enzymes.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):7-15. PubMed ID: 6177611
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods in heparin depolymerization: oligo-heteropolysaccharides as antithrombotic agents. New frontiers in prophylaxis of venous thrombosis.
    Fussi F; Ceppi G
    Boll Chim Farm; 1986 Sep; 125(9):339-45. PubMed ID: 3828100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis of N-alpha-(arylsulfonylglycyl)-3-amidinophenylalanine esters as active and relatively specific inhibitors of factor Xa].
    Vieweg H; Wagner G
    Pharmazie; 1987 Apr; 42(4):268. PubMed ID: 3615560
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats.
    Hérault JP; Perrin B; Jongbloet C; Pflieger AM; Bernat A; Herbert JM
    Thromb Haemost; 2000 Oct; 84(4):668-74. PubMed ID: 11057868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540).
    Petitou M; Duchaussoy P; Jaurand G; Gourvenec F; Lederman I; Strassel JM; Bârzu T; Crépon B; Hérault JP; Lormeau JC; Bernat A; Herbert JM
    J Med Chem; 1997 May; 40(11):1600-7. PubMed ID: 9171870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa.
    Buchanan MS; Carroll AR; Wessling D; Jobling M; Avery VM; Davis RA; Feng Y; Xue Y; Oster L; Fex T; Deinum J; Hooper JN; Quinn RJ
    J Med Chem; 2008 Jun; 51(12):3583-7. PubMed ID: 18510371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of synthetic pentasaccharide with high affinity for plasma antithrombin III in non-human primates.
    Cadroy Y; Hanson SR; Harker LA
    Thromb Haemost; 1993 Oct; 70(4):631-5. PubMed ID: 8115989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA; Needle SJ; Burns-Kurtis CL; Valocik RE; Koster PF; Amour AJ; Chan C; Brown D; Chaudry L; Zhou P; Patikis A; Patel C; Pateman AJ; Young RJ; Watson NS; Toomey JR
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):66-71. PubMed ID: 18645410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spectroscopic characterisation of tinofedrine (author's transl)].
    Thiele K; Posselt K; Heese J; Engel J
    Arzneimittelforschung; 1980; 30(7):1057-9. PubMed ID: 7191286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic irreversible inhibitors of coagulation enzymes.
    Shaw E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):33-42. PubMed ID: 6177606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.